GlaxoSmithKline Pharmaceuticals informs about ODR portal

Glaxosmithkline Pharmaceuticals Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 500660 | NSE: GLAXO

09 Oct 2023 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that in accordance with SEBI circular dated 31st July 2023, read with circular dated 4th August 2023, regarding establishment of a common Online Dispute Resolution Portal (ODR Portal) which harnesses online conciliation and online arbitration for resolution of disputes arising in the Indian Securities Market, the Company has completed the registration on the ODR portal. The company has enclosed the link of the ODR portal and aforesaid circulars are updated on the website of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1853.50
Dr. Reddys Labs.	1145.25
Cipla	1359.75
Lupin	2047.20
Zydus Lifesciences	1105.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.